0      0

Innovation in Technological Platforms in Biopharmaceutical Manufacturing

Jun 2, 2020 2:30pm ‐ Jun 2, 2020 3:30pm

Credits: None available.


As described in the morning session, regulatory expectations continue to evolve given the complexities associated with new products and innovation. This session will provide an opportunity to hear more about this topic in the context of an innovative vaccine facility and related sterile manufacturing requirements.


  • Stephen Mahoney, Executive Director, Global Quality & Compliance, Genentech, A Member of the Roche Group


  • Maria Hoffman, Executive Director, Supply Chain Management, Merck & Co., Inc.
  • Patricia Hughes, PhD, Branch Chief, Division of Microbiology Assessment, CDER/FDA


Credits: None available.

You must be logged in and own this session in order to post comments.